CVS Group PLC
CVSG
ISIN GB00B2863827 / Valor 3457960
CVS Group PLC
UMushroom community rating:
About company
CVS Group PLC is a prominent integrated veterinary services provider listed on the AIM of the London Stock Exchange. The company offers a wide range of veterinary services and products to pet owners and livestock farmers across the UK. CVS Group PLC is authorized and regulated by the Financial Conduct Authority, providing credit brokering services and acting as an Appointed Representative for insurance broking through Insurance Factory Ltd. With a strong presence in the veterinary industry, CVS Group PLC continues to expand its services and reach in the market.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (07.08.2024):
Revenue Growth
CVS Group PLC reported an 11.4% increase in revenue for the six months ended 31 December 2023 (H1 2024), reaching £329.9 million. This growth was supported by a like-for-like sales increase of 6.0%, aligning with the Group's organic revenue growth target of between 4% and 8%.
Adjusted EBITDA
For H1 2024, CVS Group PLC achieved an 8.9% increase in Adjusted EBITDA, amounting to £63.0 million. The Adjusted EBITDA margin stood at 19.1%, which is consistent with the company's full-year margin goal of between 19% and 23%.
Profit Metrics
CVS Group PLC's operating profit for H1 2024 was £28.6 million, a decrease of 9.2% compared to H1 2023. Profit before tax also saw a decline of 16.4%, totaling £23.4 million, while basic earnings per share dropped by 31.1% to 20.4 pence.
Leverage and Borrowings
As of 31 December 2023, CVS Group PLC's leverage was 1.15x, up from 0.60x at the same point in the previous year. This increase reflects the Group's ongoing focus on growth through mergers and acquisitions and capital investment, partially offset by strong EBITDA growth and operating cash conversion.
Dividends and Outlook
CVS Group PLC did not specify any changes to its dividend policy in the interim report. The company remains confident that its full-year results will meet market expectations, despite the challenging macroeconomic environment and inflationary pressures. The Group continues to focus on profitable expansion through acquisitions in both the UK and Australia.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1339 M
Market cap (USD)
273,537
Daily traded volume (Shares)
11.94 / 11.28
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
